Product
LY3526318
Aliases
LY3526318 ISA
5 clinical trials
7 indications
Indication
OsteoarthritisIndication
KneeIndication
painful diabetic neuropathyIndication
Low Back PainIndication
Osteoarthritis of the KneeIndication
HealthyIndication
Diabetic Peripheral Neuropathic PainClinical trial
A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic PainStatus: Recruiting, Estimated PCD: 2027-04-25
Clinical trial
Randomized Placebo-controlled Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Chronic Low Back PainStatus: Completed, Estimated PCD: 2022-06-17
Clinical trial
A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic PainStatus: Completed, Estimated PCD: 2022-06-06
Clinical trial
A Phase I, Single-Centre Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of LY3526318, and to Investigate the Effect of LY3526318 on Metformin and Simvastatin Pharmacokinetics in Healthy Male Japanese ParticipantsStatus: Withdrawn, Estimated PCD: 2022-12-08
Clinical trial
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic PainStatus: Completed, Estimated PCD: 2022-10-13